Lexaria Bioscience Corp.
(Other OTC/NBB : LXRP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Consumer Non Durables » Food Major Diversified
BYNDBeyond Meat, Inc. -0.81%131.510.0%$582.61m
MDLZMondelez International, Inc. 0.20%55.601.1%$327.67m
KHCThe Kraft Heinz Co. 0.37%35.410.9%$223.11m
GISGeneral Mills, Inc. 0.25%64.342.2%$214.24m
KKellogg Co. 0.39%69.502.5%$138.68m
CAGConagra Brands, Inc. 0.96%37.831.3%$94.03m
CPBCampbell Soup Co. 0.16%49.962.7%$87.78m
BGSB&G Foods, Inc. 0.78%29.5711.1%$33.71m
SMPLThe Simply Good Foods Co. 0.08%24.380.0%$22.01m
THSTreeHouse Foods, Inc. -1.84%43.349.9%$20.83m
LNDCLandec Corp. 0.29%10.324.8%$1.68m
DTEADAVIDsTEA, Inc. 0.82%0.901.8%$0.22m
RELVReliv' International, Inc. 0.31%4.020.2%$0.02m

Company Profile

Lexaria Bioscience Corp. is a proprietary drug delivery technology company. Its technology DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The company's technology can be applied to many different ingestible product formats, including foods, beverages, oral suspensions, tablets, and capsules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules, including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a tobacco producer for the development of smokeless, oral-based nicotine products. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.